{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:52:38Z","timestamp":1789602758128,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RTG 2155 ProMoAge"],"award-info":[{"award-number":["RTG 2155 ProMoAge"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Projekt DEAL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Advanced glycation endproducts (AGEs) are formed in a series of non-enzymatic reactions between reducing sugars and the amino groups of proteins and accumulate during aging, diabetes mellitus, chronic kidney disease and other chronic diseases. Accumulation of AGE-modifications alters protein structure and function, transforming these molecules into potential targets of the immune system, presumably triggering the production of autoantibodies against AGEs. In this study, we detected autoantibodies against AGE-modified proteins with ELISA in plasma samples of 91 patients with documented coronary artery disease (CAD), who underwent coronary artery bypass grafting (CABG) surgery. Patients with high levels of autoantibodies had a higher body mass index (BMI 28.6 vs 27.1\u00a0kg\/m<jats:sup>2<\/jats:sup>; p\u2009=\u20090.046), were more likely to suffer from chronic obstructive pulmonary disease (COPD 30% vs 9.8%; p\u2009=\u20090.018), and more likely to need dialysis after the surgery (10% vs 0%; p\u2009=\u20090.037). Our findings show a weak link between the levels of autoantibodies against AGEs and diabetes mellitus (DM 44% vs 24.4%; p\u2009=\u20090.05). In a small subpopulation of patients, antibodies against native bovine serum albumin (BSA) were detected. A growing body of research explores the potential role of antibodies against AGE-modified proteins in pathogenesis of different chronic diseases; our data confirms the presence of AGE-autoantibodies in patients with CAD and that in parallel to the AGEs themselves, they may have a potential role in concomitant clinical conditions in patients undergoing CABG surgery. Further research is necessary to verify the molecular role of these antibodies in different pathological conditions.<\/jats:p>","DOI":"10.1038\/s41598-020-73877-5","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T10:05:00Z","timestamp":1602583500000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Circulating antibodies against age-modified proteins in patients with coronary atherosclerosis"],"prefix":"10.1038","volume":"10","author":[{"given":"Edina","family":"Kor\u00e7a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Piskovatska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"B\u00f6rgermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Navarrete Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Simm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"73877_CR1","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jprot.2013.05.012","volume":"92","author":"A Simm","year":"2013","unstructured":"Simm, A. Protein glycation during aging and in cardiovascular disease. J. Proteom. 92, 248\u2013259. https:\/\/doi.org\/10.1016\/j.jprot.2013.05.012 (2013).","journal-title":"J. Proteom."},{"key":"73877_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12931-016-0363-2","volume":"17","author":"SJM Hoonhorst","year":"2016","unstructured":"Hoonhorst, S. J. M. et al. Advanced glycation endproducts and their receptor in different body compartments in COPD. Respir. Res. 17, 46 (2016).","journal-title":"Respir. Res."},{"key":"73877_CR3","doi-asserted-by":"publisher","unstructured":"Kay, A. M., Simpson, C. L. & Stewart, J. A. The role of AGE\/RAGE signaling in diabetes-mediated vascular calcification. J. Diabetes Res. 2016, 6809703. https:\/\/doi.org\/10.1155\/2016\/6809703 (2016).","DOI":"10.1155\/2016\/6809703"},{"key":"73877_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.kint.2017.11.034","volume":"93","author":"N Rabbani","year":"2018","unstructured":"Rabbani, N. & Thornalley, P. J. Advanced glycation end products in the pathogenesis of chronic kidney disease. Kidney Int. 93, 803\u2013813 (2018).","journal-title":"Kidney Int."},{"key":"73877_CR5","doi-asserted-by":"publisher","first-page":"e22039","DOI":"10.1002\/jcla.22039","volume":"31","author":"F Akhter","year":"2017","unstructured":"Akhter, F., Salman Khan, M., Faisal, M., Alatar, A. A. & Ahmad, S. Detection of circulating auto-antibodies against ribosylated-LDL in diabetes patients. J. Clin. Lab. Anal. 31, e22039 (2017).","journal-title":"J. Clin. Lab. Anal."},{"key":"73877_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3109\/08916934.2014.941059","volume":"48","author":"S Alam","year":"2015","unstructured":"Alam, S., Arif, Z. & Alam, K. Glycated-H2A histone is better bound by serum anti-DNA autoantibodies in SLE patients: Glycated-histones as likely trigger for SLE?. Autoimmunity 48, 19\u201328 (2015).","journal-title":"Autoimmunity"},{"key":"73877_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1046\/j.1365-2249.2000.01188.x","volume":"120","author":"AH Tai","year":"2000","unstructured":"Tai, A. H. & Newkirk, M. M. An autoantibody targeting glycated IgG is associated with elevated serum immune complexes in rheumatoid arthritis (RA). Clin. Exp. Immunol. 120, 188\u2013193 (2000).","journal-title":"Clin. Exp. Immunol."},{"key":"73877_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cellimm.2014.12.007","volume":"293","author":"JM Ashraf","year":"2015","unstructured":"Ashraf, J. M., Arfat, M. Y., Arif, Z., Ahmad, J. & Alam, K. A clinical correlation of anti-DNA-AGE autoantibodies in type 2 diabetes mellitus with disease duration. Cell. Immunol. 293, 74\u201379 (2015).","journal-title":"Cell. Immunol."},{"key":"73877_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.pcd.2018.05.002","volume":"12","author":"LH Rayner","year":"2018","unstructured":"Rayner, L. H. et al. Type 2 diabetes: A protective factor for COPD?. Prim. Care Diabetes 12, 438\u2013444. https:\/\/doi.org\/10.1016\/j.pcd.2018.05.002 (2018).","journal-title":"Prim. Care Diabetes"},{"key":"73877_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.humimm.2012.10.008","volume":"74","author":"S Ahmad","year":"2013","unstructured":"Ahmad, S., Habib, S. & Ali, A. Preferential recognition of epitopes on AGE\u2013IgG by the autoantibodies in rheumatoid arthritis patients. Hum. Immunol. 74, 23\u201327 (2013).","journal-title":"Hum. Immunol."},{"key":"73877_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11882-014-0429-5","volume":"14","author":"GA Mueller","year":"2014","unstructured":"Mueller, G. A., Maleki, S. J. & Pedersen, L. C. The molecular basis of peanut allergy. Curr. Allergy Asthma Rep. 14, 429 (2014).","journal-title":"Curr. Allergy Asthma Rep."},{"key":"73877_CR12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/nu9080835","volume":"9","author":"M Teodorowicz","year":"2017","unstructured":"Teodorowicz, M., van Neerven, J. & Savelkoul, H. Food processing: The influence of the Maillard reaction on immunogenicity and allergenicity of food proteins. Nutrients 9, 835 (2017).","journal-title":"Nutrients"},{"key":"73877_CR13","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00726-010-0776-z","volume":"42","author":"FJ Tessier","year":"2012","unstructured":"Tessier, F. J. & Birlouez-Aragon, I. Health effects of dietary Maillard reaction products: The results of ICARE and other studies. Amino Acids 42, 1119\u20131131 (2012).","journal-title":"Amino Acids"},{"key":"73877_CR14","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1210\/jc.2014-3925","volume":"100","author":"J Uribarri","year":"2015","unstructured":"Uribarri, J. et al. Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: A link between healthy and unhealthy obesity?. J. Clin. Endocrinol. Metab. 100, 1957\u20131966 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"73877_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/10408398.2016.1152949","volume":"58","author":"RK Gupta","year":"2018","unstructured":"Gupta, R. K. et al. Maillard reaction in food allergy: Pros and cons. Crit. Rev. Food Sci. Nutr. 58, 208\u2013226 (2018).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"73877_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1365-2567.2009.03199.x","volume":"129","author":"T Hilmenyuk","year":"2010","unstructured":"Hilmenyuk, T. et al. Effects of glycation of the model food allergen ovalbumin on antigen uptake and presentation by human dendritic cells. Immunology 129, 437\u2013445 (2010).","journal-title":"Immunology"},{"key":"73877_CR17","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s00394-013-0494-x","volume":"52","author":"M Teodorowicz","year":"2013","unstructured":"Teodorowicz, M., Fiedorowicz, E., Kostyra, H., Wichers, H. & Kostyra, E. Effect of Maillard reaction on biochemical properties of peanut 7S globulin (Ara h 1) and its interaction with a human colon cancer cell line (Caco-2). Eur. J. Nutr. 52, 1927\u20131938 (2013).","journal-title":"Eur. J. Nutr."},{"key":"73877_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jaci.2009.08.013","volume":"125","author":"A Ilchmann","year":"2010","unstructured":"Ilchmann, A. et al. Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: Role of macrophage scavenger receptor class A type I and II. J. Allergy Clin. Immunol. 125, 175\u2013183 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"73877_CR19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jaci.2016.05.040","volume":"139","author":"PK Smith","year":"2017","unstructured":"Smith, P. K., Masilamani, M., Li, X.-M. & Sampson, H. A. The false alarm hypothesis: Food allergy is associated with high dietary advanced glycation end-products and proglycating dietary sugars that mimic alarmins. J. Allergy Clin. Immunol. 139, 429\u2013437 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"73877_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/ACI.0000000000000385","volume":"17","author":"PK Smith","year":"2017","unstructured":"Smith, P. K. Do advanced glycation end-products cause food allergy?. Curr. Opin. Allergy Clin. Immunol. 17, 325\u2013331 (2017).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"73877_CR21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1370\/afm.2292","volume":"16","author":"R Yu","year":"2018","unstructured":"Yu, R., Yang, B., Cai, L., Lu, X. & Wang, X. Excess free fructose beverages and allergy in children and adolescents: Results from NHANES 2005\u20132006. Ann. Fam. Med. 16, 408\u2013418 (2018).","journal-title":"Ann. Fam. Med."},{"key":"73877_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.atherosclerosis.2016.10.012","volume":"254","author":"LC de Vos","year":"2016","unstructured":"de Vos, L. C., Lefrandt, J. D., Dullaart, R. P. F., Zeebregts, C. J. & Smit, A. J. Advanced glycation end products: An emerging biomarker for adverse outcome in patients with peripheral artery disease. Atherosclerosis 254, 291\u2013299 (2016).","journal-title":"Atherosclerosis"},{"key":"73877_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11892-017-0891-2","volume":"17","author":"C Lu\u00e9vano-Contreras","year":"2017","unstructured":"Lu\u00e9vano-Contreras, C., G\u00f3mez-Ojeda, A., Mac\u00edas-Cervantes, M. H. & Garay-Sevilla, M. E. Dietary advanced glycation end products and cardiometabolic risk. Curr. Diabetes Rep. 17, 63 (2017).","journal-title":"Curr. Diabetes Rep."},{"key":"73877_CR24","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.metabol.2005.02.017","volume":"54","author":"R Sampathkumar","year":"2005","unstructured":"Sampathkumar, R., Balasubramanyam, M., Rema, M., Premanand, C. & Mohan, V. A novel advanced glycation index and its association with diabetes and microangiopathy. Metabolism 54, 1002\u20131007. https:\/\/doi.org\/10.1016\/j.metabol.2005.02.017 (2005).","journal-title":"Metabolism"},{"key":"73877_CR25","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s00391-013-0523-7","volume":"47","author":"A Simm","year":"2014","unstructured":"Simm, A. et al. Intraoperative sRAGE kinetics. A new age-related outcome predictor of cardiac surgery. Z. Gerontol. Geriatr. 47, 666\u2013672. https:\/\/doi.org\/10.1007\/s00391-013-0523-7 (2014).","journal-title":"Z. Gerontol. Geriatr."},{"key":"73877_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2005.01.022","volume":"300","author":"T Mogues","year":"2005","unstructured":"Mogues, T., Li, J., Coburn, J. & Kuter, D. J. IgG antibodies against bovine serum albumin in humans\u2014their prevalence and response to exposure to bovine serum albumin. J. Immunol. Methods 300, 1\u201311 (2005).","journal-title":"J. Immunol. Methods"},{"key":"73877_CR27","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1074\/mcp.M116.058008","volume":"15","author":"S Bhat","year":"2016","unstructured":"Bhat, S. et al. Proteomic insight reveals elevated levels of albumin in circulating immune complexes in diabetic plasma. Mol. Cell. Proteom. 15, 2011\u20132020 (2016).","journal-title":"Mol. Cell. Proteom."},{"key":"73877_CR28","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jdiacomp.2016.01.012","volume":"30","author":"MF Lopes-Virella","year":"2016","unstructured":"Lopes-Virella, M. F., Hunt, K. J., Baker, N. L., Virella, G. & Investigators, V. G. O. High levels of AGE-LDL, and of IgG antibodies reacting with MDA-lysine epitopes expressed by oxLDL and MDA-LDL in circulating immune complexes predict macroalbuminuria in patients with type 2 diabetes. J. Diabetes Complicat. 30, 693\u2013699 (2016).","journal-title":"J. Diabetes Complicat."},{"key":"73877_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1749-6632.2009.05287.x","volume":"1193","author":"MA Gonzalez-Gay","year":"2010","unstructured":"Gonzalez-Gay, M. A., Gonzalez-Juanatey, C., Vazquez-Rodriguez, T. R., Miranda-Filloy, J. A. & Llorca, J. Insulin resistance in rheumatoid arthritis: The impact of the anti-TNF-\u03b1 therapy. Ann. N. Y. Acad. Sci. 1193, 153\u2013159 (2010).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"73877_CR30","doi-asserted-by":"publisher","first-page":"175346581775052","DOI":"10.1177\/1753465817750524","volume":"12","author":"AD Morgan","year":"2018","unstructured":"Morgan, A. D., Zakeri, R. & Quint, J. K. Defining the relationship between COPD and CVD: What are the implications for clinical practice?. Ther. Adv. Respir Dis. 12, 1753465817750524. https:\/\/doi.org\/10.1177\/1753465817750524 (2018).","journal-title":"Ther. Adv. Respir Dis."},{"key":"73877_CR31","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0057-2018","author":"KF Rabe","year":"2018","unstructured":"Rabe, K. F., Hurst, J. R. & Suissa, S. Cardiovascular disease and COPD: Dangerous liaisons?. Eur. Respir. Rev. https:\/\/doi.org\/10.1183\/16000617.0057-2018 (2018).","journal-title":"Eur. Respir. Rev."},{"key":"73877_CR32","doi-asserted-by":"publisher","first-page":"860","DOI":"10.4239\/wjd.v5.i6.860","volume":"5","author":"J Zhao","year":"2014","unstructured":"Zhao, J., Randive, R. & Stewart, J. A. Molecular mechanisms of AGE\/RAGE-mediated fibrosis in the diabetic heart. World J. Diabetes 5, 860\u2013867. https:\/\/doi.org\/10.4239\/wjd.v5.i6.860 (2014).","journal-title":"World J. Diabetes"},{"key":"73877_CR33","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/j.1476-5381.2012.01984.x","volume":"167","author":"MB Sukkar","year":"2012","unstructured":"Sukkar, M. B. et al. RAGE: A new frontier in chronic airways disease. Br. J. Pharmacol. 167, 1161\u20131176. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.01984.x (2012).","journal-title":"Br. J. Pharmacol."},{"key":"73877_CR34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1440-1843.2011.02118.x","volume":"17","author":"P Boschetto","year":"2012","unstructured":"Boschetto, P., Beghe, B., Fabbri, L. M. & Ceconi, C. Link between chronic obstructive pulmonary disease and coronary artery disease: Implication for clinical practice. Respirology 17, 422\u2013431. https:\/\/doi.org\/10.1111\/j.1440-1843.2011.02118.x (2012).","journal-title":"Respirology"},{"key":"73877_CR35","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/ijms18030652","volume":"18","author":"J Lewis","year":"2017","unstructured":"Lewis, J. et al. Plausible roles for RAGE in conditions exacerbated by direct and indirect (secondhand) smoke exposure. Int. J. Mol. Sci. 18, 652 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"73877_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.rmed.2010.11.001","volume":"105","author":"L Wu","year":"2011","unstructured":"Wu, L., Ma, L., Nicholson, L. F. B. & Black, P. N. Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD. Respir. Med. 105, 329\u2013336 (2011).","journal-title":"Respir. Med."},{"key":"73877_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/nu8030125","volume":"8","author":"R Clarke","year":"2016","unstructured":"Clarke, R., Dordevic, A., Tan, S., Ryan, L. & Coughlan, M. Dietary advanced glycation end products and risk factors for chronic disease: A systematic review of randomised controlled trials. Nutrients 8, 125 (2016).","journal-title":"Nutrients"},{"key":"73877_CR38","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1038\/s41598-017-02268-0","volume":"7","author":"E Baye","year":"2017","unstructured":"Baye, E., Kiriakova, V., Uribarri, J., Moran, L. J. & Courten, B. D. Consumption of diets with low advanced glycation end products improves cardiometabolic parameters: Meta-analysis of randomised controlled trials. Sci. Rep. 7, 2266 (2017).","journal-title":"Sci. Rep."},{"key":"73877_CR39","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11892-013-0453-1","volume":"14","author":"H Vlassara","year":"2014","unstructured":"Vlassara, H. & Uribarri, J. Advanced glycation end products (AGE) and diabetes: Cause, effect, or both?. Curr. Diabetes Rep. 14, 453 (2014).","journal-title":"Curr. Diabetes Rep."},{"key":"73877_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-3-319-07320-0_14","volume-title":"Oxidative Stress and Inflammation in Non-communicable Diseases-Molecular Mechanisms and Perspectives in Therapeutics","author":"A Gugliucci","year":"2014","unstructured":"Gugliucci, A. & Menini, T. Oxidative Stress and Inflammation in Non-communicable Diseases-Molecular Mechanisms and Perspectives in Therapeutics 191\u2013208 (Springer, New York, 2014)."},{"key":"73877_CR41","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1681\/ASN.2014101047","volume":"27","author":"AEM Stinghen","year":"2016","unstructured":"Stinghen, A. E. M., Massy, Z. A., Vlassara, H., Striker, G. E. & Boullier, A. Uremic toxicity of advanced glycation end products in CKD. J. Am. Soc. Nephrol. 27, 354\u2013370 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"73877_CR42","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.clnu.2017.03.019","volume":"37","author":"J Scheijen","year":"2018","unstructured":"Scheijen, J. et al. Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study. Clin. Nutr. 37, 919\u2013925. https:\/\/doi.org\/10.1016\/j.clnu.2017.03.019 (2018).","journal-title":"Clin. Nutr."},{"key":"73877_CR43","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10719-016-9705-z","volume":"33","author":"N Rabbani","year":"2016","unstructured":"Rabbani, N., Xue, M. & Thornalley, P. J. Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics. Glycoconj. J. 33, 513\u2013525. https:\/\/doi.org\/10.1007\/s10719-016-9705-z (2016).","journal-title":"Glycoconj. J."},{"key":"73877_CR44","doi-asserted-by":"publisher","first-page":"12094","DOI":"10.1021\/acs.jafc.9b03520","volume":"67","author":"D Xu","year":"2019","unstructured":"Xu, D. et al. Degradation of peptide-bound maillard reaction products in gastrointestinal digests of glyoxal-glycated casein by human colonic microbiota. J. Agric. Food Chem. 67, 12094\u201312104. https:\/\/doi.org\/10.1021\/acs.jafc.9b03520 (2019).","journal-title":"J. Agric. Food Chem."},{"key":"73877_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/nu11020386","author":"ER Miranda","year":"2019","unstructured":"Miranda, E. R. et al. Divergent changes in plasma AGEs and sRAGE isoforms following an overnight fast in T1DM. Nutrients https:\/\/doi.org\/10.3390\/nu11020386 (2019).","journal-title":"Nutrients"},{"key":"73877_CR46","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.4049\/jimmunol.1402869","volume":"195","author":"D Engelbertsen","year":"2015","unstructured":"Engelbertsen, D. et al. Low levels of IgM antibodies against an advanced glycation endproduct-modified apolipoprotein B100 peptide predict cardiovascular events in nondiabetic subjects. J. Immunol. 195, 3020\u20133025. https:\/\/doi.org\/10.4049\/jimmunol.1402869 (2015).","journal-title":"J. Immunol."},{"key":"73877_CR47","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.bbrc.2011.03.040","volume":"407","author":"K Mera","year":"2011","unstructured":"Mera, K. et al. An autoantibody against N\u03b5-(carboxyethyl) lysine (CEL): Possible involvement in the removal of CEL-modified proteins by macrophages. Biochem. Biophys. Res. Commun. 407, 420\u2013425 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"73877_CR48","first-page":"347","volume":"8","author":"MW Mashitah","year":"2015","unstructured":"Mashitah, M. W. et al. Immunization of AGE-modified albumin inhibits diabetic nephropathy progression in diabetic mice. Diabetes Metab. Syndr. Obes. Targets Ther. 8, 347 (2015).","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"73877_CR49","unstructured":"Gruber, L. S. Anti-age antibodies for treating inflammation and auto-immune disorders. Patent United States: 2020-03-10 Publication of US10584180B."},{"key":"73877_CR50","unstructured":"Gruber, L. S. Anti-age antibodies for treating neurodegenerative disorders. Patent WIPO (PCT): 2017-10-19 Publication of WO2017181116A1."},{"key":"73877_CR51","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/00005176-200308000-00009","volume":"37","author":"C Rodr\u00edguez-Juan","year":"2003","unstructured":"Rodr\u00edguez-Juan, C. et al. Increased levels of bovine serum albumin antibodies in patients with type 1 diabetes and celiac disease-related antibodies. J. Pediatr. Gastroenterol. Nutr. 37, 132\u2013135 (2003).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"73877_CR52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1081\/IAS-120027223","volume":"25","author":"DC Andersen","year":"2004","unstructured":"Andersen, D. C. et al. High prevalence of human anti-bovine IgG antibodies as the major cause of false positive reactions in two-site immunoassays based on monoclonal antibodies. J. Immunoassay Immunochem. 25, 17\u201330 (2004).","journal-title":"J. Immunoassay Immunochem."},{"key":"73877_CR53","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S0006-291X(02)00381-9","volume":"293","author":"S Tanabe","year":"2002","unstructured":"Tanabe, S. et al. Some human B and T cell epitopes of bovine serum albumin, the major beef allergen. Biochem. Biophys. Res. Commun. 293, 1348\u20131353 (2002).","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73877-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73877-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73877-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T21:20:50Z","timestamp":1670361650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73877-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["73877"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-73877-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,13]]},"assertion":[{"value":"27 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17105"}}